|
|
|
|
|
|
|
|
|
|
|
27.08.25 - 23:51
|
FDA Revokes Emergency Authorization For COVID-19 Vaccines (ZeroHedge)
|
|
|
FDA Revokes Emergency Authorization For COVID-19 Vaccines
The Department of Health and Human Services under Health Secretary Robert F. Kennedy Jr. revoked emergency authorization for COVID-19 vaccines.
"The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded," Kennedy posted to X on Wednesday.
I promised 4 things:
1. to end covid vaccine mandates.
2. to keep vaccines available to people who want them, especially the vulnerable.
3. to demand placebo-controlled trials from companies.
4. to end the emergency.
In a series of FDA actions today we accomplished…
— Secretary Kennedy (@SecKennedy) August 27, 2025
The news comes as the FDA, which is part of HHS, announced the approval of the Pfizer-BioNTech COVID-19 vaccine for older adults and children as young as 5-years-old who have at least one condition that puts them at higher risk of severe COVID-19 outcomes, Pfizer said in a W...
|
|
|
|
|
|
|
|
|
|
|
26.08.25 - 09:39
|
Pfizer Aktie nicht mehr so attraktiv bewertet - Kaufempfehlung gestrichen! (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft in einer aktuellen Aktienanalyse die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) von "kaufen" auf "halten" zurück. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 13:06
|
Leaders Come Together to Advance the Industry at Veeva Summit (PR Newswire)
|
|
|
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON,......
|
|
|
20.08.25 - 16:42
|
American Academy Of Pediatrics Pushes COVID-19 Vax For All Infants (ZeroHedge)
|
|
|
American Academy Of Pediatrics Pushes COVID-19 Vax For All Infants
In stark contrast to reality, the American Academy of Pediatrics (AAP) - which is heavily funded by pharmaceutical companies, recommended on Tuesday that young children, including infants, receive the COVID-19 vaccine despite the fact that children are minimally impacted by the virus, the fact that the vaccine doesn't prevent one from contracting it, and that it largely only helps the elderly and medically fragile from severe cases.
A 1-year-old child receives a Pfizer COVID-19 vaccination in Seattle, Wash., on June 21, 2022. David Ryder/Getty Images
According to the organization, all children ages 6-23 months should receive the COVID-19 vaccine - regardless of whether they have natural immunity from prior infection, unless they have a contraindication such as a history of severe allergic reaction to a vaccine ingredient.
While the recommendation is universal, the group said in a statement that their recommendation stems f...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
